[1]
|
《牛血清白蛋白脂质体包封率的测定方法研究》[J].药学学报,2007(5). |
[2]
|
|
[2] Daly RJ,Sanderson GM,Janes PW,et al.Cloning and characterizationof GRB14,a novel member of the GRB7 gene family[J].J BiolChem,1996,271(21):12502-12510. |
[4]
|
|
[3] Ramsey B,Bai T,Hanlon Newell A,et al.GRB7 protein over-expression and clinical outcome in breast cancer[J].BreastCancer Res Treat,2010,127(3):659-669. |
[6]
|
|
[4] Tsai NP,Ho PC,Wei LN,et al.Regulation of stress granuledynamics by Grb7 and FAK signalling pathway[J].EMBO J,2008,27(5):715-726.<br> |
[5] Luzy JP,Chen H,Gril B,et al.Development of binding assays forthe SH2 domain of Grb7 and Grb2 using fluorescence polarization[J].J Biomol Screen,2008,13(2):112-119. |
[9]
|
|
[6] Lucas-Fernandez E,Garcia-Palmero I,Villalobo A.Genomicorganization and control of the grb7 gene family[J].CurrGenomics,2008,9(1):60-68. |
[11]
|
|
[7] Tanaka S,Pero SC,Taguchi K,et al.Specific peptide ligand forGrb7 signal transduction protein and pancreatic cancer metastasis[J].J Natl Cancer Inst,2006,98(7):491-498. |
[13]
|
|
[8] Han DC,Shen TL,Guan JL.The Grb7 family proteins:structure,interactions with other signaling molecules and potential cellularfunctions[J].Oncogene,2001,20(44):6315-6321. |
[15]
|
|
[9] Junker H,Venz S,Zimmermann U,et al.Stage-related alterationsin renal cell carcinoma-comprehensive quantitative analysis by2D-DIGE and protein network analysis[J].PloS ONE,2011,6(7):e21867. |
[17]
|
|
[10] Ivancic M,Spuches AM,Guth EC,et al.Backbone nuclearrelaxation characteristics and calorimetric investigation of thehuman Grb7-SH2/erbB2 peptide complex[J].Protein Sci,2005,14(6):1556-1569. |
[19]
|
|
[11] Stein D,Wu J,Fuqua SA,et al.The SH2 domain protein GRB-7is co-amplified,overexpressed and in a tight complex with HER2in breast cancer[J].EMBO J,1994,13(6):1331-1340. |
[21]
|
|
[12] Janes PW,Lackmann M,Church WB,et al.Structuraldeterminants of the interaction between the erbB2 receptor andthe Src homology 2 domain of Grb7[J].J Biol Chem,1997,272(13):8490-8497. |
[23]
|
|
[13] Alessio N,Michele C,Anna G,et al.Grb7 upregulaion is amolecular adaptation to HER2 signaling inhibition due to removalof akt-mediated gene repression[J].PloS ONE,2010,5(2):e9024. |
[25]
|
|
[14] Ambaye ND,Gunzburg MJ,Lim RC,et al.Benzopyrazinederivatives:a novel class of growth factor receptor bound protein7 antagonists[J].Bioorg Med Chem,2011,19(1):693-701. |
[27]
|
|
[15] Mee YK,Sunjoo J.In vitro selection of RNA aptamer and specifictargeting of ErbB2 in breast cancer cells[J].Nucl Acid Ther,2011,21(3):173-178. |
[29]
|
|
[16] Jan Cl,Yu CC,Hung MC,et al.Tid1,CHIP and ErbB2interactions and their prognostic implications for breast cancerpatients[J].J Pathol,2011,225(3):424-437. |
[31]
|
|
[17] Glynn RW,Miller N,Kerin MJ.17q12-21-the pursuit of targetedtherapy in breast cancer[J].Cancer Treat Rev,2010,36(3):224-229.<br> |
[18] Pero SC,Shukla GS,Cookson MM,et al.Combination treatmentwith Grb7 peptide and Doxorubicin or Trastuzumab(Herceptin)results in cooperative cell growth inhibition in breast cancer cells[J].Br J Cancer,2007,96(10):1520-1525. |
[34]
|
|
[19] Chu PY,Huang LY,Hsu CH,et al.Tyrosine phosphorylation ofgrowth factor receptor-bound protein-7 by focal adhesion kinase inthe regulation of cell migration,proliferation,and tumorigenesis[J].J Biol Chem,2009,284(30):20215-20226. |
[36]
|
|
[20] Itoh S,Taketomi A,Tanaka S,et al.Role of growth factor-receptorbound protein 7 in hepatocellular carcinoma[J].Mol CancerRes,2007,5(7):667-673. |